Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2026-07-08 16:35:31 ET · period of report 2026-07-06 · accession 0001584759-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2026-07-08 16:35 | 2026-07-06 | ORIC | Heyman Richard A. | Dir | S - Sale | $12.00 | -300 | 212.8K | -0.1% | -$3,600 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-06 | S | D | 300 | $12.00 | 212,772 | I See footnote | — | — | (F1) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. (F2) The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares. |